| What is RSS feed? | About Us |
 |
 Search Score: 5/10
Source: us.rd.yahoo.com --- 1 day ago
AP - Scientists have mapped the cascade of genetic changes that turn normal cells in the Brain and pancreas into two of the most lethal cancers. The result points to a new approach for fighting Tumors and maybe even catching them sooner. Genes blamed for one person's Brain tumor were different from the culprits for the next patient, making the puzzle of cancer genetics even more complicated. ... Source: www.nih.gov --- 1 day ago
The Cancer Genome Atlas (TCGA) Research Network, a collaborative effort funded by the National Cancer Institute (NCI) and the National Human Genome Research Institute (NHGRI) of the National Institutes of Health (NIH), today reported the first results of its large-scale, comprehensive study of the most common form of Brain cancer, glioblastoma (GBM). In a paper published Sept. 4, 2008, in the advance online edition of the journal "Nature," the TCGA team describes the discovery of new genetic mutations and other types of DNA alterations with potential implications for the diagnosis and treatment of GBM. ... Source: www.washingtonpost.com --- 1 day ago
WASHINGTON -- Scientists have mapped the cascade of genetic changes that turn normal cells in the Brain and pancreas into two of the most lethal cancers. The result points to a new approach for fighting Tumors and maybe even catching them sooner. Genes blamed for one person's Brain tumor were... ... Source: www.ncbi.nlm.nih.gov --- 54 minutes ago
Related Articles Adjustment of caregivers of pediatric patients with Brain Tumors: a cross-sectional analysis. Psychooncology. 2008 Aug 29; Authors: Hutchinson KC, Willard VW, Hardy KK, Bonner MJ Objective: The purpose of the study was to compare the psychological adjustment of caregivers of children with Brain Tumors who are on-treatment with caregivers of children who are off-treatment.Methods: Data were collected from 90 participants: 47 (52.2%) caregivers of children undergoing active treatment (on-treatment) and 43 (47.8%) caregivers of children off-treatment on measures of global psychological distress and illness and caregiving related distress.Results: Results revealed that the two groups differed significantly in their reported symptoms of general psychological distress, with the off-treatment caregivers reporting significantly lower levels of general distress. However, off-treatment caregivers continued to experience elevated levels of uncertainty and caregiving burden related to their child's illness.Conclusions: There is significant evidence suggesting that the burden of caring for a child with a Brain tumor is ongoing, continuing well into the off-treatment period. These results also suggest that the psychosocial functioning of these caregivers is best assessed using measures designed specifically to evaluate illness-related psychosocial functioning (e.g. the Parent Experience of Child Illness, Impact on Family Scale). Cop ... Source: www.ncbi.nlm.nih.gov --- 4 days ago
Related Articles Phase II Study of Metronomic Chemotherapy with Thalidomide, Carboplatin-Vincristine-Fluvastatin in the Treatment of Brain Stem Tumors in Children. Arch Med Res. 2008 Oct;39(7):655-662 Authors: López-Aguilar E, Sepúlveda-Vildósola AC, Betanzos-Cabrera Y, Rocha-Moreno YG, Gascón-Lastiri G, Rivera-Márquez H, Wanzke-Del-Angel V, Cerecedo-Díaz F, Cruz-Yañez HD BACKGROUND: Brain stem Tumors (BST) constitute 20% of all intracranial Tumors. Survival for these patients has been very poor worldwide. Four different treatment schemes have been evaluated at our institution, with only a discrete increment in survival when treated with carboplatin-vincristine and fluvastatin (CVF). Low-dose, continuous antiangiogenic treatment has been recently introduced in the treatment of cancer. Our objective was to determine tumor response to metronomic chemotherapy combined with an antiangiogenic drug and fluvastatin and to calculate the survival of pediatric patients with Brain stem Tumors. METHODS: This was a phase II study. A magnetic resonance (MRI) study was made at inclusion and after the fourth course. Routine laboratory analyses were performed prior to each treatment scheme. Patients received four courses of chemotherapy every 28 days consisting of thalidomide alternating with fluvastatin every 14 days and combined with carboplatin and vincristine every 14 days followed by radiotherapy (56 cGy) and four more courses of the same chemothe ... Patterns of Brain Infiltration and Secondary Structure Formation in Supratentorial Ependymal Tumors.
Source: www.ncbi.nlm.nih.gov --- 14 days ago
Related Articles Patterns of Brain Infiltration and Secondary Structure Formation in Supratentorial Ependymal Tumors. J Neuropathol Exp Neurol. 2008 Aug 19; Authors: Lehman NL Ependymomas are generally considered to be noninfiltrative Tumors that have discrete borders with adjacent Brain tissue. Most occur in the posterior fossa or spinal cord. Supratentorial ependymal Tumors arise near the ventricular system or, more rarely, within the cerebral white matter or cortex. Presented here are 6 supratentorial ependymal Tumors, 3 that primarily involve the cerebral cortex and 3 that extend into the cortex from the underlying white matter. By microscopy, all of these Tumors locally infiltrate the cortex and/or white matter along small blood vessels and axonal fiber tracts. They also form other glioma secondary structures including perineuronal tumor cell satellitosis and subpial tumor cell mounds. The 3 cortical ependymal Tumors show a spectrum of features ranging from conventional and clear-cell ependymoma-like patterns to more angiocentric glioma-like histology. Because ependymal Tumors generally have a significantly better prognosis than other infiltrating gliomas, recognition of their capacity to infiltrate adjacent cortex and white matter is important to prevent the misdiagnosis of oligodendroglioma, astrocytoma, or infiltrating glioma, not otherwise specified. Cortical ependymomas and angiocentric gliomas may comprise a group of locally ... Source: www.ajc.com --- 16 days ago
MINNEAPOLIS — Batman has always been a hero to Anna and Eric Baker. Not the comic book variety, but a furry, 38-pound, bat-eared one who patiently lets their toddler climb all over him. Now, if all goes well, he may also become a hero for the thousands of people — and tens of thousands of dogs — who each year have Brain Tumors diagnosed that are equally fatal in both. On Aug. 5, Batman was the first patient to get an experimental therapy that researchers at the University of Minnesota hope will cure his Brain cancer, which is the same kind that Sen. Ted Kennedy has. If it works for Batman and other dogs, they say, it holds enormous promise as an effective treatment for people, too. ... Source: www.physorg.com --- 9 days ago
Researchers at Barrow Neurological Institute at St. Joseph's Hospital and Medical Center recently participated in a pilot study with the Montreal Neurological Institute that suggests a certain type of MRI scanning can detect when a patient is failing Brain tumor treatment before symptoms appear. The results of the study pave the way for a proactive treatment approach. ... Source: www.moreover.com --- 17 days ago
ScienceDaily (Aug. 20, 2008) ? Dr. Edward Duckworth is part of a new generation of neurosurgeons who are making Brain surgery a lot easier on patients. ... Source: www.moreover.com --- 2 days ago
The Cancer Genome Atlas (TCGA) Research Network, a collaborative effort funded by the National Cancer Institute (NCI) and the National Human Genome Research Institute (NHGRI) of the National Institutes of Health (NIH), today reported the first ... Source: www.medicalnewstoday.com --- 4 hours ago
An array of broken, missing, and overactive genes -- some implicated for the first time -- have been identified in a genetic survey of glioblastoma, the most common and deadly form of adult Brain cancer, report scientists from Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard, together with their collaborating investigators at 18 institutions and organizations. ... Source: dogblog.dogster.com --- 15 days ago
The Atlanta Journal Constitution has an interesting article today about an experimental treatment for Brain Tumors in canines. The treatment may help in developing an effective therapy for humans. On Aug. 5, Batman was the first patient to get an experimental therapy that researchers at the University of Minnesota hope will cure his Brain cancer, which [...] ... Source: www.sciencedaily.com --- 8 days ago
New research suggests a certain type of MRI scanning can detect when a patient is failing Brain tumor treatment before symptoms appear. The results of the study pave the way for a proactive treatment approach. ... Source: www.courierpostonline.com --- 22 days ago
Dressed in her Hannah Montana shirt and grinning, Devon Sheehan, 8, was running through her home, giggling, with her little sister, Paige, 6, and her friend Kathryn Quay, 8, on a warm, sunny afternoon in August. ...
Source: www.moldova.org --- 24 days ago
German scientists say they've found the developmental process of medulloblastoma -- one of the most malignant Brain Tumors among children and teenagers.In two studies working with international scientific teams, Dr. Ulrich Schuller of Germany's Ludwig Maximilian University discovered the molecular mechanisms that lead to the development of such cerebellar Tumors.The researchers triggered genetic changes in cell populations in the brains of mice to provoke the growth of Tumors. They found medulloblastomas arose from only one type of cell -- granule cells -- and only if those cells were fully committed.Medulloblastomas are presently treated with non-specific methods, said Schuller. ... Source: www.kctv5.com --- 16 days ago
A meeting is under way in Cameron about a disturbing trend of Brain Tumors. ... Source: www.streetinsider.com --- 18 days ago
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Alnylam+%28ALNY%29+and+Isis+%28ISIS%29+Pharmaceuticals%27+Joint+Venture+Announce+New+Research+on+miR-21+in+Brain+Tumors/3925101.html for the full story. ... Source: www.genengnews.com --- 18 days ago
... Source: www.lifescript.com --- 20 days ago
WASHINGTON (Reuters) - Impotence drugs may help carry cancer-fighting drugs through the Brain to treat malignant Tumors, U.S. researchers reported on Monday. Tests in rats showed two erectile dysfunction... ... Find more results for Brain Tumors on RSSMicro.com |
Copyright © 2008 RSSMicro.com
Many of these studies found that Tumors are more likely to occur on the side of the head or neck where the phone is most regularly held. more... | PDA ...